Israeli heart pump co Magenta Medical raises $105m

Heart surgery credit: Shutterstock
Heart surgery credit: Shutterstock

The company has developed a miniature heart pump that can be inserted into the body through minimally invasive surgery.

Israeli miniature heart pump developer Magenta Medical has today announced the completion of a $105 million financing round led by Novo Holdings with new investors Viking Global Investors and RA Capital Management, and existing investors OrbiMed, New Enterprise Associates (NEA), JVC Investment Partners, and ALIVE - Israel HealthTech Fund, also participated in this round.

This is Magenta’s fifth financing round, with the company raising $55 million in its most recent financing round last year. With offices and laboratories in Kadima Tzoran, Magenta has now raised more than $200 million.

The company said the financing will be used to advance its US clinical programs in multiple mechanical circulatory support (MCS) indications and to secure FDA marketing approval for its Elevate small heart pump system in patients undergoing high-risk percutaneous coronary interventions (HR-PCI).

Magenta Medical CEO Dr. David Israeli told "Globes," "Since the most recent financing round we have successfully completed a feasibility trial. Ahead of us is a much bigger trial which will represent the infrastructure for approval and sales of our product. This trial requires resources as well expansion of the company in the US and so we have created the conditions in which the investors have been convinced that there is good feasibility as well as allowing us the horizon of activity that the company needs in the coming years.

The company successfully completed its first clinical trial in leading US centers over the past year and has presented its results in several international conferences. The company is now preparing for its advanced clinical trial in order to receive FDA marketing approval.

Magenta Medical was founded in 2012 by experienced entrepreneurs Prof. Ehud Schwammenthal and Dr. Yosi Tuva who had previously founded heart valve developer Ventor, which was sold to Medtronic in 2009 for $350 million.

Initially the company focused on developing a pump designed for the kidneys, for the treatment of patients suffering from acute heart failure. However, Magenta decided to change direction due to the understanding that the time it would take to reach the final result, as well as to receive the required regulatory approvals, would be longer than expected. Moreover, the pump intended for the kidneys was the first of its kind in the world, making it more difficult for the medical devices market to adopt. A similar existing product would have further undermined its economic value.

"We took the company's core technologies, which is, as mentioned, the miniaturized pump, and decided to target it on the heart," Dr. Israeli tells Globes. "We came to the conclusion that the ability to bring such a product to market is nearer and more immediate."

The company’s current Elevate product, is a miniaturized blood pump that can be inserted into the arteries when folded, through minimally invasive surgery through the groin. Inside the heart, the pump opens up and becomes a tiny and powerful device. Thus the device can be inserted into the body in a percutaneous procedure, and relatively low risk.

The purpose of the pump is, among other things, to provide support during acute events of decreased heart function, in situations of low blood pressure and disturbed blood flow to the vital organs.

According to Magenta, medical equipment for mechanical heart support is a high growth market.

Published by Globes, Israel business news - en.globes.co.il - on July 23, 2024.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024.

Heart surgery credit: Shutterstock
Heart surgery credit: Shutterstock
Unframe founders credit: Yossi Yarom Israeli AI enterprise platform co Unframe raises $50m

Unframe’s turnkey AI solutions enable companies to solve any enterprise AI use case at scale with fully functional, customized AI solutions for businesses in a matter of hours, rather than months.

Combatica credit: Combatica Combatica launches next-gen VR AI training platform

The Israeli company's virtual reality platform includes 50 AI generated scenarios, seven maps and even situations for operating night vision.

Shekel credit: Shutterstock Vladirina 32 Shekel volatility after US tariffs announcement

The shekel is weakening sharply against the euro, which is gaining following the unveiling of Donald Trump's tariffs plan.

Minister of Finance Bezalel Smotrich credit: Noam Moskovitz Knesset Spokesperson Treasury assesses potential damage to Israel's US exports

Israel will be charged a higher tariff on its exports to the US - its biggest export customer - than Turkey and the UAE.

Iranian flag credit: Shutterstock Why inflation haunts Iran

With a month-on-month increase of 3.3% and an annual rate of 37.1%, inflation reflects the struggles of millions of Iranians.

APM merges with lawyers from Doron, Tikotzky Kantor, Gutman credit: Eyal Merilos APM merges with 12 lawyers from Doron, Tikotzky Kantor, Gutman

With the addition of these 12 lawyers, Amit Pollak Matalon & Co. will now have 135 lawyers.

US President Donald Trump credit: Reuters Sipa USA Israel on list as Trump unveils tariffs

Relatively low reciprocal tariffs will be imposed on Israeli goods sold in the US.

Deflated unicorn credit: Shutterstock Big Tech 50 reports more huge falls in startup valuations

Israeli R&D partnership Big Tech 50 reports that an investment of $2 million in Orcam made in 2021, shrank to just $31,000 at the end of 2024.

NextFerm technologies based on yeast credit: NextFerm Food-tech co NextFerm suspends operations

The company, which produces food ingredients in yeast without genetic engineering, cannot pay its debts and is seeking a buyer.

Minister of Finance Bezalel Smotrich credit: Shlomi Yosef OECD sees recovery in growth but high inflation

The OECD Israel Economic Survey 2025 recommends that the Israeli government take several restraining measures, in order to exit the economic storm created by the war.

Dano Ben-Hur credit: Dror Sithakol Statisticians contradict BoI on impact of housing finance deals

The Central Bureau of Statistics insists the impact of 20/80 buy now pay later financing deals on the real estate market and housing prices is minimal.

Governor of the Bank of Israel Amir Yaron  credit: Government Press Office Debt fears top Bank of Israel's concerns

Most unusually, Governor of the Bank of Israel Amir Yaron's press conference last week did not focus on inflation and the impending interest rate decision.

US President Donald Trump  credit: Reuters/Leah Millis Israel moves to avoid Trump's tariffs axe

Minister of Finance Bezalel Smotrich has signed an order canceling all tariffs on imports from the US. The impact will mostly be on agricultural produce.

Forbes Rich List credit: Shutterstock Maslowski Marcin Wiz founders ranked in Forbes 2025 Rich List

There are a few dozen Israelis listed in the 2025 Forbes Real-Time Billionaires List including Wiz founders Assaf Rappaport, Yinon Costica, Roy Reznik and Ami Luttwak.

SatixFy CEO Nir Barkan credit: Ariel Barkan Canada's MDA Space to buy Israeli satcom co SatixFy

MDA Space will pay $269 million for the Israeli company, including taking on a $76 million debt and a 75% premium on SatixFy's closing price on Nasdaq yesterday.

Raising dollars credit: Shutterstock Israeli startups raised over $1b in March

Israeli privately-held tech companies have raised $2.1 billion in the first three months of 2025, according to IVC-LeumiTech, up 24% from the corresponding quarter of 2024.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018